If you could vote on Brexit now which option would you choose?

AstraZeneca starts to make modest profit from COVID-19 vaccine

AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the drugmaker is in talks with several countries about new orders for delivery next year. AstraZeneca made a commitment to sell the shot developed with Oxford University at cost during the pandemic and in a press conference on Friday said low-income nations would continue to receive the vaccine on a no-profit basis, while a post-pandemic commercial approach would apply to other new orders even as infections in Europe rise again

Reuters - November 12, 2021

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-makes-over-1-bln-q3-vaccine-sales-small-profit-2021-11-12/